BridgeMD
New treatment option for Venous Thromboembolic Disease
Official title Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
ClinicalTrials.gov ID: NCT06232551
What this study is testing
- What it's testing
- A new algorithm derived from only patient age and components of the complete blood count and basic metabolic panel can identify patients discharged from the hospital who may benefit from a blood thinner (called rivaroxaban) to decrease their risk of blood clots, and for whom the risk of bleeding is minimal. The purpose of this study is to evaluate the use of a pop-up alert, which will be seen by clinicians when a discharging patient has been identified as being someone for whom the risk of blood clots is high, but for whom bleeding risk is estimated to be low.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 110
You may be able to join if
- Discharging clinician must be in one of the following iCentra electronic health record (Cerner, Kansas City, MO) positions:
- Physician, nurse practitioner, or physician assistant hospitalist
- Physician internal medicine
- Physician family medicine
- Patient age ≥ 18 years.
You likely can't join if
- Pregnant during encounter
- Discharge order completed by ineligible clinician type
- Exclude all cases where the patient is being actively prescribed and intended to be discharged on the following qualifying anticoagulant medications...
- Apixaban
- Dabigatran
- Dalteparin
See the full eligibility criteria
- Discharging clinician must be in one of the following iCentra electronic health record (Cerner, Kansas City, MO) positions:
- Physician, nurse practitioner, or physician assistant hospitalist
- Physician internal medicine
- Physician family medicine
- Patient age ≥ 18 years.
- The encounter must be inpatient.
- A signed hospital discharge order must be present.
- eVTE target population criteria (increased venous thromboembolism risk, low bleeding risk) must be met
- Pregnant during encounter
- Discharge order completed by ineligible clinician type
- Exclude all cases where the patient is being actively prescribed and intended to be discharged on the following qualifying anticoagulant medications, regardless of dose form or dosing regimen (i.e., they have an active...
- Apixaban
- Dabigatran
- Dalteparin
- Enoxaparin
- Edoxaban
- Betrixaban
- Fondaparinux
- Rivaroxaban
- Warfarin
- Creatinine clearance \<30 milliliters/minute based on last-available eligible serum creatinine value preceding discharge
- Estimated creatine clearance based on actual body weight (preferred) ((140 - age years) \ measured weight kilograms) / (72.0 \ serum creatine milligrams/deciliter) (\ 0.85 if female)) = milliliters/minute
- If measured body weight not available, then based on ideal body weight ((140 - age years) \ ideal body weight kilograms) / (72.0 \ serum creatine milligrams/deciliter) (\ 0.85 if female)) = milliliters/minute
The study team makes the final eligibility decision.
Where it's taking place
- Murray, Utah, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 110 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Murray, Utah, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.